We are live on ! Find out more
LMAT icon

LeMaitre Vascular

145 hedge funds and large institutions have $541M invested in LeMaitre Vascular in 2019 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 59 increasing their positions, 42 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 42

20% more capital invested

Capital invested by funds: $452M → $541M (+$89.6M)

0.5% more ownership

Funds ownership: 79.25%79.76% (+0.5%)

3% less funds holding

Funds holding: 150145 (-5)

26% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 19

Holders
145
Holders Change
-5
Holders Change %
-3.33%
% of All Funds
3.17%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
14
Increased
59
Reduced
42
Closed
19
Calls
$341K
Puts
Net Calls
+$341K
Net Calls Change
+$341K

LMAT Hedge Fund Activity: Q3 2019 in Review

145 of the 4,574 institutional investors tracked by Wall St. Rank reported a position in LeMaitre Vascular (LMAT) for Q3 2019, worth a combined $541M — up 20% from $452M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of LMAT and 14 opened new positions — a net loss of 5 holders — while 42 trimmed existing stakes and 59 added.

The largest buyer was Russell Investments Group, adding an estimated $5.53M. The largest seller was Millennium Management, exiting entirely with an estimated $7.83M sold.

  • 145 institutional investors held LeMaitre Vascular (LMAT) as of Q3 2019, down from 150 in Q2 2019.
  • Funds reported $541M of LeMaitre Vascular stock for Q3 2019, up 20% quarter-over-quarter.
  • 14 funds opened new LeMaitre Vascular positions in Q3 2019 and 19 closed out, a net change of -5 holders.
  • The largest LeMaitre Vascular buyer in Q3 2019 was Russell Investments Group, an estimated $5.53M added.
  • The largest LeMaitre Vascular seller in Q3 2019 was Millennium Management, an estimated $7.83M sold.

Based on aggregated 13F filings for Q3 2019.